McNinch v. The Guardian Life Insurance Company of America

CourtDistrict Court, N.D. Illinois
DecidedMarch 18, 2021
Docket1:19-cv-02305
StatusUnknown

This text of McNinch v. The Guardian Life Insurance Company of America (McNinch v. The Guardian Life Insurance Company of America) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McNinch v. The Guardian Life Insurance Company of America, (N.D. Ill. 2021).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

TERANCE MCNINCH and PEGGY MCNINCH,

Plaintiffs, Case No. 19-cv-02305

v. Judge Mary M. Rowland

THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA,

Defendant.

MEMORANDUM OPINION AND ORDER Plaintiffs Terance McNinch and Peggy McNinch (“Plaintiffs”) filed this action against Defendant The Guardian Life Insurance Company (“Defendant”) under the Employee Retirement Income Security Act of 1974 (ERISA), 29 U.S.C. § 1132(a)(1)(B). Plaintiffs seek recovery of accidental death insurance benefits under an employee welfare benefit plan provided to their son, decedent Jason McNinch (“Jason”), as an employee of the Chicago Museum of Contemporary Art. Before the Court is Plaintiffs’ motion to exclude Defendant’s expert, Dr. Daniel J. Martin, Ph.D., ABPP (“Dr. Martin”). (Dkt. 52). For reasons stated herein, Plaintiffs’ Motion to Exclude [52, 53] is denied. I. Background On October 31, 2017, Chicago Police conducted a well-being check and found 44- year-old Jason McNinch unresponsive at his residence. (Dkt. 53). He was pronounced dead later that day. Id. The Cook County Medical Examiner determined the cause of death to be combined drug (cocaine and fentanyl) toxicity. Id. Defendant denied the parents’ claim based on the life insurance plan’s policy exclusion for losses caused by the “voluntary use of a controlled substance.” (Dkt. 53 at 5; Dkt. 61 at 2). Plaintiffs

filed this action against Defendant to recover accidental death benefits. Defendant has offered a report authored by Dr. Martin on July 1, 2020 (Dkt. 53-1 (Exh. A)) and supplemented on October 8, 2020 (Dkt. 61-1 (Exh. A)).1 Defendant argues that Dr. Martin’s expert opinion will help the Court determine whether the loss was caused by Jason’s “voluntary use of a controlled substance.” (Dkt. 61 at 3). In his report, Dr. Martin provided a summary of his qualifications and also

attached his CV. (Dkt. 53-1). He is a board-certified psychologist with a Ph.D. in Clinical Psychology, licensed in three states. Dr. Martin has worked in the substance use disorder field for more than 25 years. He also completed a Predoctoral and a Postdoctoral Fellowship at the Yale University School of Medicine focusing on psychotherapy and assessment with adolescents and adults. He conducted clinical trials investigating substance use disorders at Yale. Dr. Martin has published research articles on the treatment of substance use disorders in scientific journals

and has been involved in conducting clinical trials and treating patients. Dr. Martin offered the following opinions in his report: (1) Jason likely met the DSM-5 diagnoses of Opioid Use Disorder, Alcohol Use Disorder, and Stimulant Use

1 As Plaintiffs point out, the Supplemental Report was due July 3, 2020 but was submitted on October 9, 2020 with Defendant’s Response. This 3-month delay did not prejudice Plaintiffs, however. The Supplemental Report contains no new opinions. It added to Dr. Martin’s description of his methodology, but this was not a substantial change. Plaintiffs also had the opportunity to respond to the Supplemental Report in their Reply brief. Disorder (cocaine) for which he underwent intermittent treatment and experienced relapses; (2) Jason had a history of nasal heroin and cocaine use—possibly using the substances simultaneously and possibly using them separately; (3) the substances in

Jason’s system at the time of his death are consistent with a substance use disorder; (4) Jason’s methadone treatment was likely coupled with psychoeducation and counseling that would have informed him of the risks of substance use including death; (5) cocaine is usually cut or combined with other substances, including fentanyl; (6) it is likely that Jason was aware that he was self-administering the controlled substances and that a doctor did not prescribe them; and (7) it is more

likely than not that Jason was aware that cocaine is often mixed with other substances based on his substance use history and treatment. (Dkt. 61-1). Plaintiffs have moved to exclude Dr. Martin’s opinions as not satisfying the standards set forth in Federal Rule of Evidence 702 and Daubert v. Merrell Dow Pharms., Inc., 509 U.S. 579 (1993). They challenge the reliability and relevance of Dr. Martin’s report, but not his qualifications. II. Standard

Under Daubert, 509 U.S. 579, the requirements of Federal Rule of Evidence 702 must be met before an expert can testify. The court evaluates the expert’s qualifications, reliability of the methodology, and relevance of the testimony: “In performing its gatekeeper role under Rule 702 and Daubert, the district court must engage in a three-step analysis before admitting expert testimony. It must determine whether the witness is qualified; whether the expert’s methodology is scientifically reliable; and whether the testimony will assist the trier of fact to understand the evidence or to determine a fact in issue.” Gopalratnam v. Hewlett-Packard Co., 877 F.3d 771, 779 (7th Cir. 2017) (internal citations and quotations omitted). District

courts have “significant discretion under the flexible Daubert inquiry.” Lapsley v. Xtek, Inc., 689 F.3d 802, 818 (7th Cir. 2012). The burden is on the party seeking to admit the expert to show by a preponderance of the evidence that the expert meets the requirements of Rule 702 and Daubert. Gopalratnam, 877 F.3d at 782.2 Because “there are many different kinds of experts, and many different kinds of expertise, . . .the gatekeeping inquiry must be ‘tied to the facts’ of a particular case.”

Kumho Tire Co. v. Carmichael, 526 U.S. 137, 150, 119 S. Ct. 1167, 1175 (1999) (quoting Daubert, 509 U.S. at 591). With regard to reliability, “the key to the gate is not the ultimate correctness of the expert’s conclusions. Instead, it is the soundness and care with which the expert arrived at her opinion.” C.W. v. Textron, Inc., 807 F.3d 827, 834 (7th Cir. 2015) (internal citations and quotations omitted). While the Daubert inquiry focuses on principles and methodology, the “soundness of the factual underpinnings of the expert’s analysis and the correctness of the expert’s conclusions

based on that analysis are factual matters to be determined by the trier of fact, or, where appropriate, on summary judgment.” Smith v. Ford Motor Co., 215 F.3d 713, 718 (7th Cir. 2000).

2 Under Rule 702, “A witness who is qualified as an expert by knowledge, skill, experience, training, or education may testify in the form of an opinion or otherwise if: (a) the expert's scientific, technical, or other specialized knowledge will help the trier of fact to understand the evidence or to determine a fact in issue; (b) the testimony is based on sufficient facts or data; (c) the testimony is the product of reliable principles and methods; and (d) the expert has reliably applied the principles and methods to the facts of the case.” Fed. R. Evid.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
Mark A. Smith v. Ford Motor Company
215 F.3d 713 (Seventh Circuit, 2000)
Balkar Dhillon v. Crown Controls Corporation
269 F.3d 865 (Seventh Circuit, 2001)
Leonard Lapsley v. Xtek, Inc.
689 F.3d 802 (Seventh Circuit, 2012)
Crespo v. Unum Life Insurance Co. of America
294 F. Supp. 2d 980 (N.D. Illinois, 2003)
Brandon Stollings v. Ryobi Technologies, Inc.
725 F.3d 753 (Seventh Circuit, 2013)
C.W. Ex Rel. Wood v. Textron, Inc.
807 F.3d 827 (Seventh Circuit, 2015)
S. Gopalratnam v. ABC Insurance Company
877 F.3d 771 (Seventh Circuit, 2017)
Porter v. Whitehall Laboratories, Inc.
9 F.3d 607 (Seventh Circuit, 1993)

Cite This Page — Counsel Stack

Bluebook (online)
McNinch v. The Guardian Life Insurance Company of America, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mcninch-v-the-guardian-life-insurance-company-of-america-ilnd-2021.